When it comes to supplements, most people aren’t looking for miracles, just something that quietly fits into their routine ...

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk reduction.

Novo Nordisk’s Wegovy weight-loss pill is now broadly available across the U.S., two weeks after it received U.S. regulatory ...

Tums and Rolaids are both antacids that provide fast relief from heartburn, indigestion, and upset stomach. Rolaids works faster and lasts longer than Tums due to its magnesium hydroxide content. The ...

Capsules are generally easier to swallow than tablets. Tablets have a long shelf life and are usually cheaper than capsules. Capsules and tablets serve the same purpose but vary in taste, composition, ...

Tablet lubricants play a key role in pharmaceutical manufacturing, affecting everything from compression behavior to tablet performance and regulatory compliance. If you’ve ever faced challenges with ...

The FDA has approved a tablet version of zanubrutinib for all indications, improving convenience and reducing pill burden for patients with blood cancers. The FDA has approved a new tablet formulation ...

An oral tablet formulation of zanubrutinib was approved for use in patients with certain lymphomas or leukemia and Waldenström macroglobulinemia. An oral tablet formulation of zanubrutinib (Brukinsa) ...

Formulation challenges can feel like roadblocks — from API incompatibility and dissolution delays to safety concerns and inconsistent tablet performance. When you face obstacles in tablet lubrication, ...

When selecting the appropriate formulation of Livmarli, the patient's weight and ability to swallow tablets should be considered. Livmarli tablets are supplied in 10mg, 15mg, 20mg, and 30mg dosage ...

Cyprumed and MSD signed a nonexclusive license and option agreement to develop oral formulations of MSD’s peptides using Cyprumed’s innovative drug delivery technology. MSD gains nonexclusive global ...